These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32966713)

  • 21. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
    Joyce MG; Wheatley AK; Modjarrad K
    Cell; 2020 Jul; 182(1):7-9. PubMed ID: 32649880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to: SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases.
    Outeiro TF; Krisko A
    Mov Disord; 2020 Jul; 35(7):1106-1107. PubMed ID: 32502289
    [No Abstract]   [Full Text] [Related]  

  • 23. How COVID-19 can damage the brain.
    Marshall M
    Nature; 2020 Sep; 585(7825):342-343. PubMed ID: 32934351
    [No Abstract]   [Full Text] [Related]  

  • 24. Community-Acquired Respiratory Viruses in Oncology: Lessons to Be Learnt from the SARS-CoV-2 Pandemic.
    von Lilienfeld-Toal M
    Oncol Res Treat; 2020; 43(6):262-263. PubMed ID: 32408304
    [No Abstract]   [Full Text] [Related]  

  • 25. Physical distancing, face masks, and eye protection for prevention of COVID-19.
    MacIntyre CR; Wang Q
    Lancet; 2020 Jun; 395(10242):1950-1951. PubMed ID: 32497511
    [No Abstract]   [Full Text] [Related]  

  • 26. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
    French MA; Moodley Y
    Respirology; 2020 Jul; 25(7):680-682. PubMed ID: 32436320
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.
    Lee YL; Liao CH; Liu PY; Cheng CY; Chung MY; Liu CE; Chang SY; Hsueh PR
    J Infect; 2020 Aug; 81(2):e55-e58. PubMed ID: 32335168
    [No Abstract]   [Full Text] [Related]  

  • 29. Temperature and the difference in impact of SARS CoV-2 infection (COVID-19) between tropical and non-tropical regions in Taiwan.
    Hsu YL; Lin HC; Wei HM; Lai HC; Hwang KP
    Travel Med Infect Dis; 2020; 36():101790. PubMed ID: 32544431
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.
    Zheng M; Song L
    Cell Mol Immunol; 2020 May; 17(5):536-538. PubMed ID: 32132669
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to "Does hand hygiene reduce SARS-CoV-2 transmission?".
    Lai THT; Tang EWH; Fung KSC; Li KKW
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1135. PubMed ID: 32222828
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-reaction of Sera from COVID-19 Patients with SARS-CoV Assays.
    Wan WY; Lim SH; Seng EH
    Ann Acad Med Singap; 2020 Jul; 49(7):523-526. PubMed ID: 33000119
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia.
    Hussain T; Saman HT; Yousaf Z
    Am J Trop Med Hyg; 2020 Oct; 103(4):1742-1743. PubMed ID: 32851969
    [No Abstract]   [Full Text] [Related]  

  • 34. The COVID-19 pandemic in the USA: what might we expect?
    Chowell G; Mizumoto K
    Lancet; 2020 Apr; 395(10230):1093-1094. PubMed ID: 32247381
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
    Varga Z; Flammer AJ; Steiger P; Haberecker M; Andermatt R; Zinkernagel A; Mehra MR; Scholkmann F; Schüpbach R; Ruschitzka F; Moch H
    Lancet; 2020 May; 395(10238):e100. PubMed ID: 32442527
    [No Abstract]   [Full Text] [Related]  

  • 37. Going back in time for an antibody to fight COVID-19.
    Whittaker GR; Daniel S
    Nature; 2020 Jul; 583(7815):203-204. PubMed ID: 32623442
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Chan KH; Slim J
    Emerg Infect Dis; 2020 Oct; 26(10):2535. PubMed ID: 32614765
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    Zeng Z; Chen L; Pan Y; Deng Q; Ye G; Li Y; Wang X
    J Infect; 2020 Jul; 81(1):e80-e81. PubMed ID: 32283140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.